Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 8/20 | 0.78 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23094245 | 0.79 | TDP1 (1.00) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094273 | 0.78 | TDP1 (0.69) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094207 | 0.78 | TDP1 (0.78) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094211 | 0.76 | ALDH1A1 (0.86) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094247 | 0.76 | TDP1 (1.00) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094156 | 0.76 | TDP1 (1.00) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094254 | 0.74 | TP53 (0.71) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094226 | 0.74 | TDP1 (0.60) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094250 | 0.74 | MAPT (0.81) | TDP1L3MBTL1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL23094169 | 0.74 | MAPT (0.81) | TDP1L3MBTL1SMN1; SMN2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947188-B2 | Small molecule ferroptosis inducers | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2021-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947188-B2 | Small molecule ferroptosis inducers | GPX4, AIFM2, GPX1 | TDP1 4664/4885L3MBTL1 2077/4885SMN1; SMN2 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.